Indications for ELLA:

Prevention of pregnancy following unprotected intercourse or known or suspected contraceptive failure. Not for use as regular contraceptive.


Take 1 tab as soon as possible within 120hrs (5 days) after unprotected intercourse or contraceptive failure. May repeat dose if vomiting occurs within 3hrs.


Premenarchal: not applicable.


Known/suspected pregnancy.


Not for termination of an existing pregnancy. Exclude pregnancy before prescribing. Rule out ectopic pregnancy if lower abdominal pain occurs. Rule out pregnancy if subsequent menses delayed by >1 week. Does not protect against HIV or other STDs. Repeat use within same menstrual cycle: not recommended. Nursing mothers.

Pharmacologic Class:

Progesterone agonist/antagonist.


Avoid concomitant CYP3A4 inducers (eg, barbiturates, bosentan, carbamazepine, felbamate, griseofulvin, oxcarbazepine, phenytoin, rifampin, topiramate, St. John's wort). Potentiated by CYP3A4 inhibitors (eg, ketoconazole, itraconazole). May antagonize regular hormonal contraceptives; use barrier contraception for remainder of menstrual cycle and resume oral contraceptives ≥5 days after dose.

Adverse Reactions:

Headache, abdominal pain, nausea, dysmenorrhea, fatigue, dizziness; menstrual cycle changes.

How Supplied:


Pricing for ELLA

30mg tablet (Qty: 1)
Appx. price $41